EGFR和TREM—1在食管癌中的表达及黄芪多糖通过抑制炎症因子辅助食管癌治疗的作用研究(4)
[3] Sakanaka K, Ishida Y, Fujii K,et al. Long-term outcome of definitive radiotherapy for cervical esophageal squamous cell carcinoma. Radiat Oncol. 2018;13(1):7.
[4] Zhai S, Xue J, Wang Z,et al.. High expression of special AT-rich sequence binding protein-1 predicts esophageal squamous cell carcinoma relapse and poor prognosis. Oncol Lett. 2017;14(6):7455-7460.
[5] Luo Y, Mao Q, Wang X,et al. Radiotherapy for esophageal carcinoma: dose, response and survival. Cancer Manag Res. 2017;10:13-21.
[6] Harada E, Serada S, Fujimoto M, et al. Glypican-1 targeted antibody-based therapy induces preclinical antitumor activity against esophageal squamous cell carcinoma. Oncotarget. 2017;8(15):24741-24752.
[7] Anvari K, Sima HR, Seilanian Toussi M, et al. EGFR Expression in Patients withEsophageal Squamous Cell Carcinoma and its Association with Pathologic Response to Preoperative Chemoradiotherapy: A Study in Northeastern Iran. Arch Iran Med. 2017;20(4):240-245.
[8] Chen CL, Wang Y, Huang CY, et al. IL-17 induces antitumor immunity by promoting beneficial neutrophil recruitment and activation in esophageal squamous cell carcinoma. Oncoimmunology. 2017;7(1):e1373234.
[7] Chen CL, Wang Y, Huang CY, et al. IL-17 induces antitumor immunity by promoting beneficial neutrophil recruitment and activation in esophageal squamous cell carcinoma. Oncoimmunology. 2017;7(1):e1373234.
[9] Shang QX, Yang YS, Xu LY, et al. Prognostic significance and role in TNM stage of tumor deposits in esophageal cancer. J Thorac Dis. 2017;9(11):4461-4476.
[10] Zheng WB, Li YJ, Wang Y, et al. Propafenone suppresses esophageal cancer proliferation through inducing mitochondrial dysfunction. Am J Cancer Res. 2017;7(11):2245-2256.
[11] Wang X, Niu H, Fan Q, et al. Predictive value of EGFR overexpression and gene amplification on icotinib efficacy in patients with advanced esophageal squamous cell carcinoma. Oncotarget. 2016;7(17):24744-51.
[12] Huang J, Fan Q, Lu P, et al. Icotinib in Patients with Pretreated Advanced Esophageal Squamous Cell Carcinoma with EGFR Overexpression or EGFR Gene Amplification: A Single-Arm, Multicenter Phase 2 Study. J Thorac Oncol. 2016;11(6):910-7.
[13] Huang WH, Liao WR, Sun RX. Astragalus polysaccharide induces the apoptosis of human hepatocellular carcinoma cells by decreasing the expression of Notch1. Int J Mol Med. 2016;38(2):551-7., 百拇医药(孙小虎 王璐于洪张文陆)
[4] Zhai S, Xue J, Wang Z,et al.. High expression of special AT-rich sequence binding protein-1 predicts esophageal squamous cell carcinoma relapse and poor prognosis. Oncol Lett. 2017;14(6):7455-7460.
[5] Luo Y, Mao Q, Wang X,et al. Radiotherapy for esophageal carcinoma: dose, response and survival. Cancer Manag Res. 2017;10:13-21.
[6] Harada E, Serada S, Fujimoto M, et al. Glypican-1 targeted antibody-based therapy induces preclinical antitumor activity against esophageal squamous cell carcinoma. Oncotarget. 2017;8(15):24741-24752.
[7] Anvari K, Sima HR, Seilanian Toussi M, et al. EGFR Expression in Patients withEsophageal Squamous Cell Carcinoma and its Association with Pathologic Response to Preoperative Chemoradiotherapy: A Study in Northeastern Iran. Arch Iran Med. 2017;20(4):240-245.
[8] Chen CL, Wang Y, Huang CY, et al. IL-17 induces antitumor immunity by promoting beneficial neutrophil recruitment and activation in esophageal squamous cell carcinoma. Oncoimmunology. 2017;7(1):e1373234.
[7] Chen CL, Wang Y, Huang CY, et al. IL-17 induces antitumor immunity by promoting beneficial neutrophil recruitment and activation in esophageal squamous cell carcinoma. Oncoimmunology. 2017;7(1):e1373234.
[9] Shang QX, Yang YS, Xu LY, et al. Prognostic significance and role in TNM stage of tumor deposits in esophageal cancer. J Thorac Dis. 2017;9(11):4461-4476.
[10] Zheng WB, Li YJ, Wang Y, et al. Propafenone suppresses esophageal cancer proliferation through inducing mitochondrial dysfunction. Am J Cancer Res. 2017;7(11):2245-2256.
[11] Wang X, Niu H, Fan Q, et al. Predictive value of EGFR overexpression and gene amplification on icotinib efficacy in patients with advanced esophageal squamous cell carcinoma. Oncotarget. 2016;7(17):24744-51.
[12] Huang J, Fan Q, Lu P, et al. Icotinib in Patients with Pretreated Advanced Esophageal Squamous Cell Carcinoma with EGFR Overexpression or EGFR Gene Amplification: A Single-Arm, Multicenter Phase 2 Study. J Thorac Oncol. 2016;11(6):910-7.
[13] Huang WH, Liao WR, Sun RX. Astragalus polysaccharide induces the apoptosis of human hepatocellular carcinoma cells by decreasing the expression of Notch1. Int J Mol Med. 2016;38(2):551-7., 百拇医药(孙小虎 王璐于洪张文陆)
参见:首页 > 医疗版 > 疾病专题 > 消化内科 > 食管疾病 > 食管癌